Edwards To Launch Surgical LAAC In 2026 As Structural Heart Expansion Accelerates

 
• By Shubham Singh
  
IRVINE, CALIFORNIA - 7 MAY 2023: Edwards Lifesciences is a global leader in medical innovations for structural heart disease, critical care and surgical monitoring.
Edwards expects average annual sales growth of 10%, alongside constant currency operating margin expansion. (Shutterstock)

More from Strategy

More from Business